Staley Capital Advisers Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Staley Capital Advisers Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.41 $24,000 - $82,000	-200,000 Reduced 33.33%	400,000 $52,000
Q2 2020 Aug 07, 2020	BUY	$0.52 - $0.92 $52,000 - $92,000	100,000 Added 20.0%	600,000 $464,000
Q4 2019 Feb 04, 2020	BUY	$0.63 - $2.27 $63,000 - $227,000	100,000 Added 25.0%	500,000 $1.14 Million
Q3 2019 Nov 08, 2019	BUY	$0.59 - $0.9 $118,000 - $180,000	200,000 Added 100.0%	400,000 $252,000
Q2 2019 Aug 09, 2019	BUY	$0.79 - $1.11 $158,000 - $222,000	200,000 New	200,000 $171,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Staley Capital Advisers Inc with notifications on news.